These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 10633159

  • 21. Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.
    Aceto MD, Scates SM, Lowe JA, Martin BR.
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1290-5. PubMed ID: 8819514
    [Abstract] [Full Text] [Related]

  • 22. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide.
    Mallet PE, Beninger RJ.
    Psychopharmacology (Berl); 1998 Nov; 140(1):11-9. PubMed ID: 9862397
    [Abstract] [Full Text] [Related]

  • 23. Tolerance to the disruptive effects of Delta(9)-THC on learning in rats.
    Delatte MS, Winsauer PJ, Moerschbaecher JM.
    Pharmacol Biochem Behav; 2002 Dec; 74(1):129-40. PubMed ID: 12376160
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Critical role of the endogenous cannabinoid system in mouse pup suckling and growth.
    Fride E, Ginzburg Y, Breuer A, Bisogno T, Di Marzo V, Mechoulam R.
    Eur J Pharmacol; 2001 May 11; 419(2-3):207-14. PubMed ID: 11426843
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cannabimimetic properties of ajulemic acid.
    Vann RE, Cook CD, Martin BR, Wiley JL.
    J Pharmacol Exp Ther; 2007 Feb 11; 320(2):678-86. PubMed ID: 17105826
    [Abstract] [Full Text] [Related]

  • 29. Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist.
    De Vry J, Rüdiger Jentzsch K.
    Eur J Pharmacol; 2002 Dec 20; 457(2-3):147-52. PubMed ID: 12464360
    [Abstract] [Full Text] [Related]

  • 30. A role for central cannabinoid and opioid systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in mice.
    Reche I, Fuentes JA, Ruiz-Gayo M.
    Eur J Pharmacol; 1996 Apr 22; 301(1-3):75-81. PubMed ID: 8773449
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.
    Anikwue R, Huffman JW, Martin ZL, Welch SP.
    J Pharmacol Exp Ther; 2002 Oct 22; 303(1):340-6. PubMed ID: 12235269
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
    Järbe TU, Liu Q, Makriyannis A.
    Psychopharmacology (Berl); 2006 Jan 22; 184(1):36-45. PubMed ID: 16307294
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Neuronal responses to cannabinoid receptor ligands in the solitary tract nucleus.
    Himmi T, Perrin J, El Ouazzani T, Orsini JC.
    Eur J Pharmacol; 1998 Oct 16; 359(1):49-54. PubMed ID: 9831292
    [Abstract] [Full Text] [Related]

  • 40. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.
    Norwood CS, Cornish JL, Mallet PE, McGregor IS.
    Eur J Pharmacol; 2003 Mar 28; 465(1-2):105-14. PubMed ID: 12650839
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.